派博傳思國際中心

標(biāo)題: Titlebook: Epigenetics in Oncology; Jianjun Chen,G. Greg Wang,Jun Lu Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licen [打印本頁]

作者: Destruct    時間: 2025-3-21 16:52
書目名稱Epigenetics in Oncology影響因子(影響力)




書目名稱Epigenetics in Oncology影響因子(影響力)學(xué)科排名




書目名稱Epigenetics in Oncology網(wǎng)絡(luò)公開度




書目名稱Epigenetics in Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Epigenetics in Oncology被引頻次




書目名稱Epigenetics in Oncology被引頻次學(xué)科排名




書目名稱Epigenetics in Oncology年度引用




書目名稱Epigenetics in Oncology年度引用學(xué)科排名




書目名稱Epigenetics in Oncology讀者反饋




書目名稱Epigenetics in Oncology讀者反饋學(xué)科排名





作者: CYN    時間: 2025-3-21 20:26

作者: LITHE    時間: 2025-3-22 02:06

作者: 外表讀作    時間: 2025-3-22 05:27

作者: 磨碎    時間: 2025-3-22 09:34

作者: peptic-ulcer    時間: 2025-3-22 13:06

作者: peptic-ulcer    時間: 2025-3-22 21:03

作者: 喪失    時間: 2025-3-23 00:39
Histone Readers and Their Roles in Cancer the partitioning of the genome into distinctive compartments and domains. One of the major functions of histone modifications is to recruit reader proteins, which recognize the epigenetic marks and transduce the molecular signals in chromatin to downstream effects. Histone readers are defined prote
作者: 憎惡    時間: 2025-3-23 03:08

作者: 血友病    時間: 2025-3-23 06:02

作者: cliche    時間: 2025-3-23 12:17

作者: 使長胖    時間: 2025-3-23 15:02

作者: lacrimal-gland    時間: 2025-3-23 20:06
American Studies oder Amerikanistik?ngs on the engagement of epitranscriptomic pathways, especially the ones associated with .-methyladenosine (m.A), in the regulation of cancer metabolism and the surrounding microenvironment. We also discuss the promising therapeutic approaches targeting RNA modifications for anti-tumor therapy.
作者: 你正派    時間: 2025-3-23 22:25

作者: 打火石    時間: 2025-3-24 02:57
https://doi.org/10.1007/978-3-030-00575-7 RNA metabolism to drive oncogenic or tumor-suppressive cellular pathways. m.A?RNA methylation also plays dynamic roles within both immune cells and tumor cells to mediate the anti-tumor immune response. Finally, an emerging area of research within epitranscriptomics studies the role of m.A RNA meth
作者: cringe    時間: 2025-3-24 07:25
American Television on British Screensso recognized as guanosine by the splicing and translation machineries, resulting in mRNA alternative splicing and protein recoding. Therefore, A-to-I RNA editing is an important mechanism that causes and regulates “RNA mutations” in both normal physiology and diseases including cancer. In this chap
作者: convert    時間: 2025-3-24 11:58

作者: 聯(lián)合    時間: 2025-3-24 16:00
American Writers And Radical Politics1900-39ational modification regulates functionality of EZH2 and PRC2, and how PRC2 and other epigenetic pathways crosstalk. Lastly, we will briefly touch on advances in targeting EZH2 and PRC2 dependence as cancer therapeutics.
作者: 臆斷    時間: 2025-3-24 20:53
RNA Modifications in Cancer Metabolism and Tumor Microenvironmentngs on the engagement of epitranscriptomic pathways, especially the ones associated with .-methyladenosine (m.A), in the regulation of cancer metabolism and the surrounding microenvironment. We also discuss the promising therapeutic approaches targeting RNA modifications for anti-tumor therapy.
作者: 宿醉    時間: 2025-3-25 01:52
Recent Advances of RNA m6A Modifications in Cancer Immunoediting and Immunotherapypathological processes, including immune system development and cancer pathogenesis. Therefore, a deeper understanding of the mechanisms by which RNA modifications impact the cancer immunoediting process can provide insight into the mechanisms of resistance to immunotherapies and the strategies that
作者: 切碎    時間: 2025-3-25 06:09

作者: BLUSH    時間: 2025-3-25 10:55
Recent Advances in Adenosine-to-Inosine RNA Editing in Cancerso recognized as guanosine by the splicing and translation machineries, resulting in mRNA alternative splicing and protein recoding. Therefore, A-to-I RNA editing is an important mechanism that causes and regulates “RNA mutations” in both normal physiology and diseases including cancer. In this chap
作者: 周年紀(jì)念日    時間: 2025-3-25 11:42

作者: 鞠躬    時間: 2025-3-25 19:26

作者: FER    時間: 2025-3-25 22:17

作者: 售穴    時間: 2025-3-26 03:49
American Studies oder Amerikanistik?past decade have revealed that RNA chemical modifications have profound effects on tumor initiation, progression, refractory, and recurrence. Tumor cells are notorious for their robust plasticity in response to the stressful microenvironment and undergo metabolic adaptations to sustain rapid cell pr
作者: 發(fā)誓放棄    時間: 2025-3-26 07:41

作者: constellation    時間: 2025-3-26 10:39

作者: 眨眼    時間: 2025-3-26 14:27
https://doi.org/10.1007/978-3-030-00575-7NA. RNA molecules, including mRNA, tRNA, rRNA, and other non-coding RNA molecules, can be edited with numerous modifications. The most prevalent modification in eukaryotic mRNA is N6-methyladenosine (m.A), which is a reversible modification found in over 7000 human genes. Recent technological advanc
作者: 使成核    時間: 2025-3-26 18:33

作者: Aggressive    時間: 2025-3-26 21:06

作者: CRACK    時間: 2025-3-27 04:16
https://doi.org/10.1007/978-3-030-55552-8d regions at active enhancers and promoters. The mammalian SWI/SNF protein subunits are encoded by 29 genes and 11–15 subunits including an ATPase domain of either SMARCA4 (BRG1) or SMARCA2 (BRM) are assembled into a complex. Based on the distinct subunits, SWI/SNF are grouped into 3 major types (su
作者: 污點(diǎn)    時間: 2025-3-27 05:47

作者: malign    時間: 2025-3-27 13:04

作者: Epidural-Space    時間: 2025-3-27 15:36
https://doi.org/10.1057/9781137340023ot based on DNA sequence, which include those of DNA methylation, histone modification, and chromatin remodeling. Androgen receptor (AR) is the main driver for PCa and androgen deprivation therapy (ADT) remains a backbone treatment for patients with PCa; however, ADT resistance almost inevitably occ
作者: HEAVY    時間: 2025-3-27 20:30

作者: sorbitol    時間: 2025-3-28 00:03

作者: CLAY    時間: 2025-3-28 05:14
Cancer Treatment and Researchhttp://image.papertrans.cn/e/image/313243.jpg
作者: amphibian    時間: 2025-3-28 08:15
978-3-031-45656-5The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
作者: resistant    時間: 2025-3-28 12:44
Epigenetics in Oncology978-3-031-45654-1Series ISSN 0927-3042 Series E-ISSN 2509-8497
作者: ARC    時間: 2025-3-28 17:40

作者: 迅速成長    時間: 2025-3-28 22:15
Inferring the Cancer Cellular Epigenome Heterogeneity via DNA Methylation PatternsTumor cells evolve through space and time, generating genetically and phenotypically diverse cancer cell populations that are continually subjected to the selection pressures of their microenvironment and cancer treatment.
作者: adequate-intake    時間: 2025-3-28 23:01

作者: 邊緣    時間: 2025-3-29 06:18

作者: 招致    時間: 2025-3-29 08:07
https://doi.org/10.1057/9781137340023s about the dysregulation of epigenetic regulators crucially involved in the initiation, development, and progression of PCa and discuss the potential use of inhibitors targeting epigenetic modifiers for treatment of advanced PCa.
作者: LEVER    時間: 2025-3-29 12:40

作者: ADJ    時間: 2025-3-29 18:46
RNA Modifications in Cancer Stem Cell Biologynt. In this chapter, we summarize the current knowledge of the roles of RNA modifications in shaping the CSC state and driving gene expression programs that confer stem-like properties to CSCs, promote CSC adaptation to the local microenvironment, and endow CSCs with metastatic potential and drug resistance.
作者: Annotate    時間: 2025-3-29 20:16
Epigenetic (De)regulation in Prostate Cancers about the dysregulation of epigenetic regulators crucially involved in the initiation, development, and progression of PCa and discuss the potential use of inhibitors targeting epigenetic modifiers for treatment of advanced PCa.
作者: 盡忠    時間: 2025-3-30 01:49

作者: 奴才    時間: 2025-3-30 04:34
Histone Readers and Their Roles in Cancerin domains with well-organized three-dimensional structures. In this Chapter, we will outline major histone readers, delineate their biochemical and structural features in histone recognition, and describe how dysregulation of histone readout leads to human cancer.
作者: N防腐劑    時間: 2025-3-30 08:49

作者: transplantation    時間: 2025-3-30 14:51





歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
周口市| 铜陵市| 互助| 蒙城县| 高陵县| 布尔津县| 佛山市| 吉木乃县| 健康| 鞍山市| 恩施市| 巢湖市| 芮城县| 搜索| 毕节市| 清水县| 城口县| 吕梁市| 沅陵县| 化德县| 屏山县| 无锡市| 蒙自县| 七台河市| 昌都县| 肃宁县| 聊城市| 田林县| 西藏| 松原市| 绥宁县| 固原市| 达拉特旗| 三明市| 库伦旗| 武夷山市| 皋兰县| 杂多县| 南昌市| 霍林郭勒市| 扬中市|